Mangiferin decreases plasma free fatty acids through promoting its catabolism in liver by activation of AMPK

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Niu, Yucun ^a   Li, Songtao ^a   Na, Lixin ^a   Feng, Rennan ^a   Liu, Liyan ^a   Li, Ying ^a   Sun, Changhao ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRIC ACID; ACETYL COENZYME A CARBOXYLASE; ACYL COENZYME A; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; CARNITINE PALMITOYLTRANSFERASE I; CD36 ANTIGEN; DIACYLGLYCEROL ACYLTRANSFERASE 2; FATTY ACID; FENOFIBRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MANGIFERIN; OLEIC ACID; PROTEIN KINASE LKB1; TRIACYLGLYCEROL; ADENYLATE KINASE; ANTIDIABETIC AGENT; XANTHONE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CELL STRAIN HEPG2; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; ENZYME ACTIVATION; ENZYME ACTIVITY; FATTY ACID BLOOD LEVEL; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; FEMALE; HYPERLIPIDEMIA; IN VITRO STUDY; IN VIVO STUDY; LIPOLYSIS; LIVER METABOLISM; MALE; NONHUMAN; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; DOWN REGULATION; EVALUATION; HUMAN; LIPID METABOLISM; LIVER; METABOLISM; WISTAR RAT;

RATTUS; RATTUS NORVEGICUS;

ADENYLATE KINASE; ANIMALS; DOWN-REGULATION; ENZYME ACTIVATION; FATTY ACIDS, NONESTERIFIED; FEMALE; HEP G2 CELLS; HUMANS; HYPERLIPIDEMIAS; HYPOGLYCEMIC AGENTS; LIPID METABOLISM; LIVER; MALE; METABOLISM; RATS; RATS, WISTAR; TRIGLYCERIDES; XANTHONES;

EID: 84856098097     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030782     Document Type: Article

References (33)

1. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, et al. (1996) Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 97: 2859-2865.
2. Boden G, (1999) Free fatty acids, insulin resistance, and type 2 diabetes mellitus. Proc Assoc Am Physicians 111: 241-248.
3. Boden G, (2008) Obesity and free fatty acids. Endocrinol Metab Clin North Am 37: 635-646, viii-ix.
4. Wilding JP, (2007) The importance of free fatty acids in the development of Type 2 diabetes. Diabet Med 24: 934-945.
5. Boden G, Homko C, Mozzoli M, Showe LC, Nichols C, et al. (2005) Thiazolidinediones upregulate fatty acid uptake and oxidation in adipose tissue of diabetic patients. Diabetes 54: 880-885.
6. Soler-Argilaga C, Infante R, Renaud G, Polonovski J, (1974) Factors influencing free fatty acid uptake by the isolated perfused rat liver. Biochimie 56: 757-761.
7. Teusink B, Voshol PJ, Dahlmans VE, Rensen PC, Pijl H, et al. (2003) Contribution of fatty acids released from lipolysis of plasma triglycerides to total plasma fatty acid flux and tissue-specific fatty acid uptake. Diabetes 52: 614-620.
8. Diraison F, Beylot M, (1998) Role of human liver lipogenesis and reesterification in triglycerides secretion and in FFA reesterification. Am J Physiol 274: E321-327.
9. Sato T, Kawamoto A, Tamura A, Tatsumi Y, Fujii T, (1992) Mechanism of antioxidant action of pueraria glycoside (PG)-1 (an isoflavonoid) and mangiferin (a xanthonoid). Chem Pharm Bull (Tokyo) 40: 721-724.
10. Miura T, Ichiki H, Iwamoto N, Kato M, Kubo M, et al. (2001) Antidiabetic activity of the rhizoma of Anemarrhena asphodeloides and active components, mangiferin and its glucoside. Biol Pharm Bull 24: 1009-1011.
11. Miura T, Iwamoto N, Kato M, Ichiki H, Kubo M, et al. (2001) The suppressive effect of mangiferin with exercise on blood lipids in type 2 diabetes. Biol Pharm Bull 24: 1091-1092.
12. Muruganandan S, Srinivasan K, Gupta S, Gupta PK, Lal J, (2005) Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats. J Ethnopharmacol 97: 497-501.
13. Bates EJ, Topping DL, Sooranna SP, Saggerson D, Mayes PA, (1977) Acute effects of insulin on glycerol phosphate acyl transferase activity, ketogenesis and serum free fatty acid concentration in perfused rat liver. FEBS Lett 84: 225-228.
14. Pelkonen R, Miettinen TA, Taskinen MR, Nikkila EA, (1968) Effect of acute elevation of plasma glycerol, triglyceride and FFA levels on glucose utilization and plasma insulin. Diabetes 17: 76-82.
15. Bligh EG, Dyer WJ, (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911-917.
16. Liu L, Li Y, Feng R, Sun C, Direct ultrasound-assisted methylation of fatty acids in serum for free fatty acid determinations. Canadian Journal of Chemistry 88: 898-905.
17. Smith HO, Kelly TJ, Roy PH, (1974) Enzymatic methods for sequence analysis applied to DNA restriction and methylation sites. Methods in enzymology 29: 282-294.
18. Whitman SC, Sawyez CG, Miller DB, Wolfe BM, Huff MW, (1998) Oxidized type IV hypertriglyceridemic VLDL-remnants cause greater macrophage cholesteryl ester accumulation than oxidized LDL. J Lipid Res 39: 1008-1020.
19. Budinger GR, Chandel N, Shao ZH, Li CQ, Melmed A, et al. (1996) Cellular energy utilization and supply during hypoxia in embryonic cardiac myocytes. Am J Physiol 270: L44-53.
20. Ix JH, Sharma K, Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK. J Am Soc Nephrol 21: 406-412.
21. Abumrad N, Harmon C, Ibrahimi A, (1998) Membrane transport of long-chain fatty acids: evidence for a facilitated process. J Lipid Res 39: 2309-2318.
22. McGarry JD, Brown NF, (1997) The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem 244: 1-14.
23. Postic C, Girard J, (2008) Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest 118: 829-838.
24. Fukao T, Lopaschuk GD, Mitchell GA, (2004) Pathways and control of ketone body metabolism: on the fringe of lipid biochemistry. Prostaglandins Leukot Essent Fatty Acids 70: 243-251.
25. Cases S, Smith SJ, Zheng YW, Myers HM, Lear SR, et al. (1998) Identification of a gene encoding an acyl CoA:diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis. Proc Natl Acad Sci U S A 95: 13018-13023.
26. Hardie DG, (2004) The AMP-activated protein kinase pathway-new players upstream and downstream. J Cell Sci 117: 5479-5487.
27. Huang TH, Peng G, Li GQ, Yamahara J, Roufogalis BD, et al. (2006) Salacia oblonga root improves postprandial hyperlipidemia and hepatic steatosis in Zucker diabetic fatty rats: activation of PPAR-alpha. Toxicol Appl Pharmacol 210: 225-235.
28. Julius U, (2003) Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia. Exp Clin Endocrinol Diabetes 111: 246-250.
29. Kovacs P, Stumvoll M, (2005) Fatty acids and insulin resistance in muscle and liver. Best Pract Res Clin Endocrinol Metab 19: 625-635.
30. Hahn SE, Goldberg DM, (1992) Modulation of lipoprotein production in Hep G2 cells by fenofibrate and clofibrate. Biochem Pharmacol 43: 625-633.
31. Holloway GP, Bezaire V, Heigenhauser GJ, Tandon NN, Glatz JF, et al. (2006) Mitochondrial long chain fatty acid oxidation, fatty acid translocase/CD36 content and carnitine palmitoyltransferase I activity in human skeletal muscle during aerobic exercise. J Physiol 571: 201-210.
32. Fukao T, Lopaschuk GD, Mitchell GA, (2004) Pathways and control of ketone body metabolism: on the fringe of lipid biochemistry. Prostaglandins, leukotrienes, and essential fatty acids 70: 243-251.
33. Harwood HJ Jr, Petras SF, Shelly LD, Zaccaro LM, Perry DA, et al. (2003) Isozyme-nonselective N-substituted bipiperidylcarboxamide acetyl-CoA carboxylase inhibitors reduce tissue malonyl-CoA concentrations, inhibit fatty acid synthesis, and increase fatty acid oxidation in cultured cells and in experimental animals. J Biol Chem 278: 37099-37111.